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Summary. CD61 is a membrane glycoprotein that
associates with CD41 (a IIb) to form the heterodimeric
complex gpIIb/IIIa (CD41/CD61), predominantly
expressed in platelets and megakariocytes. CD61 or ß3
integrin also associates with av (CD51) to form the
vitronectin receptor, which is expressed in many tissues.
We have used a monoclonal antibody against the porcine
gpIIIa or CD61 (JM2E5) to study the distribution of this
molecule in different normal pig tissues. As in humans,
CD61 was broadly expressed in all tissues examined. In
the kidney, strong expression of CD61 was observed in
epithelial cells from renal tubules. In the testis, CD61
expression was detected in the Leydig cells. However, in
liver, CD61 was weak or not detected.
Many integrins are particularly involved in
tumogenicity and in tumor progression mediating cell-
cell interaction. Immunofluorescence experiments using
cultured human tumor HeLa cells showed nuclear and
cytoplasmic staining of mAb JM2E5. Immunohisto-
chemical analysis of human tumor sections from several
organs showed a heterogeneus distribution in metastatic
cases from colon and breast carcinoma. However, no
staining was found in metastasis from melanoma.
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Introduction
Platelet glycoproteins aIIb and ß3 (CD41/CD61) are
membrane proteins that associate to form a Ca2 +-
dependent heterodimer which constitutes a member of
the integrin family at the surface of the cell. In resting
platelets it is constitutively expressed in an inactive state
and it does not recognize soluble proteins. Platelet
activation results in a conformational change from a
l o w - a ffinity CD41/61 receptor to a high-affinity state,
which then recognizes the plasma fibrinogen,
fibronectin, von Willebrand factor, vitronectin and
thrombospondin (Kieffer and Phillips, 1990).
Monoclonal antibodies (mAbs) to gpIIb/IIIa
complex have proven to be a useful tool for functional
and structural studies of this molecule. Animal
homologues of human gpIIb/IIIa have been detected in
different species. We have reported previously a murine
mAb (JM2E5) to porcine CD41/CD61 (Pérez de la
Lastra et al., 1997). This antibody recognizes the ß3
subunit of the complex and is cross-reactive with human
gpIIb/IIIa.
In humans, CD61 or gpIIIa integrin is expressed in
cells from the megakaryocytic lineage and has been
described in human monocytes and macrophages (Prieto
et al., 1994). However, the tissue distribution of this
protein in normal human tissues is not well known. In
the III International Veterinary Immunology W r k s h o p
nd Conference on Human Leukocyte Diff e r e n t i a t i o n
Antigens (Pilkington et al., 1987), two anti-gpIIIa mAbs
w r  reactive with endothelial cells, renal glomerular
and tubular cells and smooth muscle cells. Most of the
mAbs anti gpIIb/IIIa from this workshop, showed
reactivity with bone marrow, fetal liver, lung
megakaryocytes and with a small percentage of bone
marrow blasts.
The complex CD41/CD61 is not only present in
normal tissue. It has also been found in 17 tumor cells
lines (Chen et al., 1997) derived from different species
(human, rat and mouse) and of different histological
origins: skin, blood, lung, liver, kidney, cervix, colon,
b l a d d e r, breast and prostate. In these tumor cells, the
glycoprotein could be involved in the invasion of human
elanoma cells (Trikha et al., 1997) and in the
metastatic progression of prostatic adenocarcinoma
(Trikha et al., 1998). Moreover, a number of studies have
suggested that interactions of integrins with their ligands
are associated with tumorigenicity and tumor
progression.
In this study, we tested the immunochemical
reactivity of a mAb (JM2E5) anti-pig CD61 to determine
the distribution of this glycoprotein in different normal
porcine tissues. Because integrins are involved in the
growth, invasion and metastatic properties of many types
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of tumors, the expression of CD61 integrin in tumors
was also investigated. Given that JM2E5 is cross-
reacting with human, we studied the expression of CD61
in cortexes of primary human tumors and their
metastasis.
Materials and methods
Cells and antibodies
HeLa cells were purchased from the ATTCC. JM2E5
antibody was generated in house as previously described
(Perez de la Lastra et al., 1997). Rabbit anti-mouse IgG
FITC-labeled antibody was purchased from Sigma Co.
St. Louis, USA. Rabbit anti-mouse Ig-biotinilated
antibody was purchased from DAKO Corp. Carpinteria,
USA.
Cell cultures
HeLa cells were grown in DMEM (Gibco Co USA)
supplemented with 10% FCS and 1% (v/v)
penicillin/streptomycin (Sigma) and plated in 6-well
culture plates (Corning Incorporated, Corning, New
York, USA), containing sterilized coverslips and left to
60% confluence. The cultures were serum deprived in
DMEM with BSA (1mg/ml). Cells were then washed
twice with PBS 0.1M, pH 7.4, and fixed in
paraformaldehyde (4% in PBS) for 15 min at room
temperature. After washing three times with PBS, cells
were permeabilized with 0.5% Triton X-100 for 30 min.
After washing in PBS, coverslips were incubated with
JM2E5 antibody diluted 1/20 in PBS, or with PBS as
negative control, for 1 hour at 37 °C. Cells were washed
again in PBS and stained with rabbit anti-mouse IgG
FITC-labeled (Sigma) diluted 1/25 for 1 hour at 37 °C.
F i n a l l y, coverslips were washed and mounted in
PBS/glycerol (1:1).
Histological samples
Samples from porcine tissues (collected from five
d i f erent pigs) and tumor specimens were placed
overnight into 10% buffered formalin. Five µm paraffin-
embedded sections, mounted on poly-L-lysine-coated
slides, were dewaxed in xylene and hydrated by passage
through graded alcohols. Endogenous peroxidase
activity was inhibited by treatment with 3% hydrogen
peroxide in distilled water for 30 min at room
temperature. After washing with PBS, the slides were
microwaved as previously described (Sierralta and
Thole, 1996). Briefly, slides were immersed in 10 mM
citrate buffer pH 6.0 and microwaved in an R-210a
Sharp microwave oven run 5 min at medium and twice
(3 min each one) at maximal power (800 w). After
cooling, the sections were covered with distilled water
for 20 min, washed in PBS and incubated with normal
goat serum (1:20 dilution in 1% albumin-PBS) for 30
min at room temperature. After removing the serum,
JM2E5 antibody or PBS-BSA (as negative control) was
added for 18 hours at 4 °C in a wet chamber. The
sections were washed in PBS and incubated with anti-
mouse Ig-biotinilated (DAKO), diluted 1/50 in PBS-
BSA, for 30 min at room temperature. After washing
again in PBS, tissue sections were covered with avidin-
biotin-peroxidase complex (Vector Laboratories,
Burlingame, USA) for 1 hour in a wet chamber, washed
and then developed with 3,3’-diaminobenzidine (Sigma)
(DAB: 5 mg in 10 ml PBS). Sections were counter-
stained with Carazzi hematoxylin and mounted with
Immu-mount (Shandom Inc. Pittsburgh, USA).
The percentage of stained cells (staining score) was
evaluated as 0 (no staining); 1 (0-5 %); 2 (5-50 %) and 3
(more than 50%). Staining intensity was considered as 1
( weak-moderate) and 2 (strong).
Results
Immunohistochemical reactivity of the antibody
JM2E5 specific for CD41/CD61 was tested on paraffin-
embedded sections of the following normal porcine
tissues: skin, intestine, testis, liver, spleen and kidney.
P a r a ffin-embedded sections were preferred to frozen
tissue sections due to their widespread use in diagnostic
immu ohistochemistry and for a better comparison with
the distribution of CD61 in human.
Immunohistology using the anti-gpIIIa mAb JM2E5
confirmed that CD61 was abundantly distributed in pig
tissues, particularly on cells of epithelial origin.
Negative controls using an isotype-matched mAb were
performed for each tissue. In controls, only occasional
dark brown-stained cells were observed, which were
eo inophils in which endogenous peroxidase activity
was not fully blocked. The vascular endothelium in
some organs examined was positive for pig CD61,
although the constitutive expression of this integrin in
endothelial cells has been controversial (Damjanovich et
al., 1992; Singh et al., 2000). In skin, immunoreactivity
was evident at the granular and prickle cell layers as well
as in the blood vessels and glandular cells near the
hipodermis (Fig. 1a,b). In contrast, pig CD61 was absent
from smooth muscle cells in the dermis (not shown).
Intestinal mucosa showed staining of JM2E5 in
epi helial cells of the glands, leukocytes and plasma cells
at the lamina propria (Fig. 1c). The testis was strongly
st ined for CD61, particularly the Leydig cells and
surrounding connective tissue; the germinal epithelium
in the seminiferous tubules showed a slight positivity
(Fig. 1d) and in spleen, the staining for CD61 was
located in lymphoid aggregates of the white pulp
nodules (Fig. 1e). However, CD61 was absent from the
abundant splenic supporting tissue (not shown). In the
kidney, the staining for CD61 was strong in all epithelial
cells of renal tubules (Fig. 1f), but staining of glomerular
epith lium was weak (not shown)
The expression of integrins gpIIb/IIIa in cultured
tumor cell lines is well documented. Therefore, we
tudied the expression of CD61 integrin in HeLa cells,
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using the mAb JM2E5. Immunofluorescence
experiments showed that HeLa cells were stained by
JM2E5 antibody. A staining pattern with nuclear and
cytoplasmic paranuclear expression was observed (Fig.
2). 
On this basis, we questioned whether the expression
of CD61 integrin observed in cultured tumor cells was
also found in vivo. In this sense, immunohistochemical
expression using mAb JM2E5 was investigated in
formalin-fixed, paraffin-embedded surgical samples of
human carcinomas of colon, breast and melanoma, as
well as in their metastasis.
As shown in Table 1, normal breast tissue was not
stained using mAb JM2E5 and a moderate staining for
CD61 was observed in normal skin and colon mucosa
(Fig. 3). Histological distribution of JM2E5 was
349
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Fig. 1. Immunoreactivity of JM2E5 in porcine tissues. Staining is mainly localized at the epidermis and glandular cells in skin (a, b); cytoplasmic pattern
shows leukocytes, plasma cells and epithelial cells of intestinal mucosa (c) as well as the Leydig cells in testis (d). Reactivity with lymphoid aggregates
of the white pulp in spleen ( )and epithelial cells of renal tubules(f) i  also seen. x 100
heterogeneous in all the different cancer cases (Table 1).
Colon and breast carcinoma showed atypical glandular
structures, infiltrating normal tissues and JM2E5 stained
in an intracytoplasmic fashion, with a membranous
pattern (Fig. 4a,c). This heterogeneous distribution of the
CD61 integrin was similar in all metastatic cases (Fig.
4b,d,f). In melanoma, JM2E5 staining also had a diffuse
intracytoplasmic location with a membranous pattern
(Fig. 4e). However, no staining was found in the
metastasis of melanoma (not shown).
Discussion
The complex of integrins CD41/CD61 is the most
thoroughly studied protein on platelets, but there are few
references about the distribution in tissues by
i m m u n o h i s t o c h e m i s t r y. The distribution of CD61 in
species other than man has not been thoroughly
examined. Here we provide an analysis of the
distribution of CD61 in the pig. Since platelets almost
invariably adhere to all leucocytes, only
immunohistochemical techniques make it possible to
clearly distinguish between cells expressing the antigen
and nonspecifically-stained cells. In the present study,
we h ve used immunohistochemical techniques in order
to clarify the distribution of this glycoprotein in various
normal porcine tissues 
Our data show a widespread expression of the CD61
antigen in different organs of swine corresponding to the
pattern of tissue expression for beta 3 integrin, which is
diff rent from the pattern found when mAbs specific to
CD41, the alpha IIb integrin are used. Expression of the
CD41 is restricted to the megakaryocyte/platelet lineage
(Jim et al., 1998), whereas CD61 is also present on
macrophages, monocytes and endothelial cells. CD61
forms with a v the vitronectin receptor. Recently, the
expression of a v ß3 molecule has been studied in pig,
dog and cattle tissues (Singh et al., 2001). Similarly to
our results, the a vß3 integrin is expressed on cells of
epithelial origin. Our results are also consistent with
those found in humans by Soligo et al. (1989). These
authors also suggest the possibility of the existence of
cros -reacting epitopes on gpIIb/IIIa with LFA-3 y Mac-
1 molecules, which belong to the same family of
adhesion molecules. However, we did not detect LFA-3
or Mac-1 molecules by immunoprecipitation studies
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Table 1.Distribution of JM2E5 in human tumor samples.
SPECIMENS No. OF CASES STAINING SCORE STAINING INTENSITY
0 1 2 3 1 2
Normal Colon mucosa 3 0 3 0 0 -- 3
Normal breast tissue 3 3 0 0 0 -- --
Normal skin 1 0 1 0 0 1 --
Colon Carcinoma 5 0 0 2 3 -- 5
Liver metastasis 5 0 0 4 1 1 4
Breast Carcinoma 3 0 0 2 1 -- 3
Skin metastasis 2 0 1 0 1 -- 2
Bone marrow 1 0 0 0 1 -- 1
Melanoma 1 0 0 0 1 -- 1
Fig. 2. Immunofluorescence in cultured HeLa cells showing the binding
pattern for JM2E5. x 75
Fig. 3. Human colon mucosa. Immunoreactivity in epithelial cells is
observed. x150
using the mAb JM2E5 (not shown).
In addition to the normal distribution of CD61 in the
pig, we have undertaken the expression of this integrin
in the cortex of human tumors using a mAb against
porcine gpIIIa. Concerning the expression of gpIIb/IIIa
in human tumor, several reports have been published
which demonstrate the presence of adhesion molecules
on tumor cell membrane. Adhesion molecules are
detectable with antibodies against platelet glycoproteins
and they are involved in the growth, invasion and
metastatic properties of many types of tumors (Va r n e r
and Cheresh, 1996). Particularly, the integrins are
involved in the process of tumor progression by
mediating the adhesion of tumor cells to each other and
active platelets to form tumor-platelets aggregates. The
a I I b - ß3 receptor and P-selectin on platelets are also
351
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Fig. 4. Expression of JM2E5 in colon carcinoma(a) and liver metastasis (b). Breast carcinoma (c) and skin (d) and bone marrow (f) metastatic cases.
Melanoma (e). Staining shows an intracytoplasmic location with a membranous pattern. x 150
important when the tumor cells are protected against
circulating immune cells by binding to platelets (Huang
et al., 1997). Several approaches aimed at inhibiting the
activities of these molecules have been studied in vivo
and in experimental animals for developing new
therapies and, due to their specificity and unlimited
availability, the most common approach has been to use
mAbs, such as JM2E5, which recognize adhesion
molecules (Jim et al., 1998).
The purpose of this study was to determine by
immunohistochemistry whether different human tumors
expressed the gpIIb/IIIa because little is known about the
expression of this protein in vivo, as the majority of
investigations have been carried out in cultured human
tumor cell lines. To address this question, we screened
breast, colon and melanome tumor tissue and the
analysis indicates positive staining with JM2E5 in all
these specimens, confirming the presence of alpha IIb-
beta3 in vivo. So, these results suggest that this integrin
is expressed in nonmegakaryocytic lineage solid tumor
cells. Trikha et al. (1997) found that the high aff in i t y
gpIIb/IIIa integrin is capable of directly supporting
melanoma cell adhesion and that this complex may have
important consequences on the development of the
metastatic phenotype in prostate cancer (Trikha et al.,
1998). The latter results could be in accordance with the
presence of a IIb-ß3 found by us in metastasis of skin and
l i v e r. More experiments are necessary in order to
confirm these results and the mAb JM2E5 can be very
useful in this investigation and in cancer therapy also,
because different studies (Edward, 1995; Newton et al.,
1995)) have shown that neutralizing mAbs which target
adhesion molecules is effective in inhibiting invasion,
dissemination and/or proliferation of tumor cells in
animal systems.
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